Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -41.670% | -42.466% | -41.667% | -57.360% | - | -61.290% | -86.000% |
| Viking Therapeutics Inc | -3.090% | -2.104% | 3.775% | -24.513% | -3.046% | 251.873% | 553.909% |
| Corcept Therapeutics Inc. | -52.910% | -53.163% | -53.122% | -33.004% | -52.354% | 70.799% | 48.091% |
| Medpace Holdings Inc | -0.350% | 0.786% | -2.988% | 49.341% | 0.912% | 144.110% | 330.973% |
| SELLAS Life Sciences Group Inc | 29.980% | 57.783% | 204.276% | 253.053% | 30.511% | 69.182% | -27.079% |
| Axsome Therapeutics Inc | 18.700% | 16.718% | 24.836% | 79.007% | 19.133% | 110.588% | 127.009% |
| Kala Pharmaceuticals Inc. | -9.800% | -0.947% | -51.880% | -92.614% | - | -98.917% | -99.833% |
| Intellia Therapeutics Inc | 1.230% | -1.203% | 13.020% | -33.793% | 0.974% | -75.948% | -82.488% |
| Eli Lilly Corp. | 0.020% | 1.453% | 2.490% | 21.575% | 0.447% | 167.994% | 577.967% |